Connect with us

Business

Economic uncertainty blamed for ‘lacklustre’ retail performance last month

Published

on

Economic uncertainty blamed for ‘lacklustre’ retail performance last month



Analysists have blamed rising economic uncertainty for a “lacklustre” July that saw Scottish retail sales fall in real terms compared with the same month last year.

According to figures from the Scottish Retail Consortium (SRC) and KPMG, total sales in Scotland rose 0.1% last month compared with July 2024, when they had decreased by 0.9%.

However when adjusted for inflation this represents a year-on-year fall of 0.5%.

Food sales in Scotland were down 1.4% compared with July 2024, when they had decreased by just 0.3%.

This was despite a strong opening to the month when hot weather led to a “boost” in spending on barbecues and summer meals.

Non-food sales on the other hand rose by 1.4% compared with the same period last year, with analysists saying phones and some furniture and toy ranges performed well.

Adjusted for the effects of online sales, non-food sales increased 1.6% on July 2024, when they had decreased by 1.5%.

Ewan MacDonald-Russell, deputy head of the SRC, said: “July was a lacklustre month for Scottish retailers as sales again disappointed.

“When adjusted for inflation retail sales in Scotland fell by 0.5%. That’s a slight improvement on June’s figures, but demonstrates shoppers continue to cut back on shopping as economic uncertainty continues to rise.

“Within the general disappointment there were some bright spots. Food sales shone in the opening half of the month as Scots took advantage of the warm weather to cook barbeque and summer meals.

“Phone sales did well, as did some toys and furniture ranges. Against that televisions continue to disappoint, with few households investing in high-end entertainment despite the summer plethora of sporting events.

“Fashion ranges performed poorly, albeit the likelihood is shoppers did their summer wardrobe shopping earlier in the year when the sunshine emerged.

“The harsh truth is Scots are holding back spending as worries about the economy grow.

“That is leaving shops in the lurch – facing higher costs as a consequence of last year’s UK Government budget without the growth needed to pay those bills.

“With little sight the economic weather will brighten, many retailers, especially those on the high street, face increasingly unpalatable choices in the coming months.”

Linda Ellett, UK head of consumer, retail and leisure at KPMG, described the current trading environment as “challenging” for retailers.

“The UK’s fifth warmest July on Met Office record brought a boost to home appliance and food and drink sales,” she said.

“But rising inflation was also a driver of the latter and monthly non-food sales are only growing at around 1% on average at present.

“With employment costs having risen and inflation both a business and consumer side pressure, it remains a challenging trading environment for many retailers.

“While the majority of consumers that KPMG surveys are confident in their ability to balance their monthly household budgets, big ticket purchases are more considered in the context of rising essential costs and ongoing caution about the economy and labour market.

“Holidays are the priority for many this summer but those heading away have had to account for a higher cost of travel.

“Consequently, spending in some areas of the retail sector remains subdued and competition for consumer spend will remain fierce.”

The figures were published in the SRC-KPMG Retail Sales Monitor for July.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Published

on

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site


The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.

Mike Blake | Reuters

Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the Trump administration to make the medicine more accessible.

The announcement also comes weeks after chief rival Novo Nordisk unveiled additional discounts on the cash prices of its obesity and diabetes drugs. 

Starting Monday, cash-paying patients with a valid prescription can get the starting dose of Zepbound vials for as low as $299 per month on LillyDirect, down from a previous price of $349 per month. They can also access the next dose, 5 milligrams, for $399 per month and all other doses for $449 per month, down from $499 per month across those sizes. 

Zepbound carries a list price of roughly $1,086 per month. That price point, and spotty insurance coverage for weight loss drugs in the U.S., have been significant barriers to access for some patients. 

Eli Lilly’s announcement comes just weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to get and afford. The agreements will cut the prices the government pays for the drugs, introduce Medicare coverage of obesity drugs for the first time for certain patients and offer discounted medicines on the government’s new direct-to-consumer website launching in January, TrumpRx. 

But Eli Lilly’s deal with Trump centers around lowering the prices of a different form of Zepbound – a multi-dose pen – after it wins Food and Drug Administration approval. 

That means Eli Lilly’s Monday announcement around cutting prices on the existing single-dose vials could allow more patients to get discounted treatments more quickly. 

“We will keep working to provide more options — expanding choices for delivery devices and creating new pathways for access — so more people can get the medicines they need,” said Ilya Yuffa, president of Lilly USA and global customer capabilities, in a statement. 

Eli Lilly’s stock, which has climbed more than 36% this year, fell nearly 2% on Monday. Its meteoric rise due to the success of Zepbound and its diabetes injection Mounjaro vaulted it to becoming the first health-care company to hit a $1 trillion market value last month. Though cutting prices means lower revenue per medication sold, Eli Lilly’s sales — and shares — have continued to soar through past pricing announcements as demand balloons.

With single-dose vials, patients need to use a syringe and needle to draw up the medicine and inject it into themselves. Eli Lilly first introduced that form of Zepbound in August 2024. 

It’s unclear how many patients are currently using single-dose vials of Zepbound. But Eli Lilly previously said that direct-to-consumer sales now account for more than a third of new prescriptions of Zepbound. 

Novo Nordisk earlier this month lowered the price of its obesity drug Wegovy and diabetes treatment Ozempic for existing cash-paying patients to $349 per month from $499 per month. That excludes the highest dose of Ozempic. 

The company also launched a temporary introductory offer, which will allow new cash-paying patients to access the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment. 



Source link

Continue Reading

Business

OGRA Announces LPG Price Increase for December – SUCH TV

Published

on

OGRA Announces LPG Price Increase for December – SUCH TV



The Oil and Gas Regulatory Authority (OGRA) has approved a fresh increase in the price of liquefied petroleum gas (LPG), raising the cost for both domestic consumers and commercial users.

According to the notification issued, the LPG price has been increased by Rs7.39 per kilogram, setting the new rate at Rs209 per kg for December. As a result, the price of a domestic LPG cylinder has risen by Rs87.21, bringing the new price to Rs2,466.10.

In November, the price of LPG stood at Rs201 per kg, while the domestic cylinder was priced at Rs2,378.89.

The latest price hike is expected to put additional pressure on households already grappling with rising living costs nationwide.



Source link

Continue Reading

Business

Taxable Value Of Goods Surges 15% In Sep-Oct As GST Cuts Boost Consumption

Published

on

Taxable Value Of Goods Surges 15% In Sep-Oct As GST Cuts Boost Consumption


New Delhi: The taxable value of all supplies under GST surged by a robust 15 per cent during September-October this year, compared to the same period in 2024 due to sharp increase in consumption triggered by the tax rate cuts on goods across sectors that kicked in from September 22, according to official sources.

The growth in the same two-month period last year was 8.6 per cent. “This surge in taxable value during ‘Bachat Utsav’ demonstrates strong consumption uplift, stimulated by reduced rates and improved compliance behaviour,” a senior official said.

He pointed out that the growth has especially been strong in sectors where rate rationalisation was implemented, such as FMCG, pharma goods, food products, automobiles, medical devices and textiles. In these sectors, the taxable value of supplies has seen significantly higher growth, confirming that lower GST rates translated directly into higher consumer spending.

Add Zee News as a Preferred Source


“It vindicates our strategy that reducing rates on essentials and mass-use sectors would create demand-side buoyancy — a Laffer Curve–type demand uplift,” he explained.These trends confirm that GST next-gen reforms have not disrupted revenue stability, and that consumption-side buoyancy has begun to translate into higher taxable value in key sectors.

This growth is in value terms which means that since GST rates were lower, the growth in volume terms will be even higher. It is clearly visible that while the Next Gen Reforms resulted in significant Bachat — increased consumption, industry has been very proactive in passing on the GST savings to the final consumers and ensuring that there is no supply side deficiency.

As GDP private consumption data will be released much later, GST taxable value serves as the most reliable real-time proxy for consumption, and the current numbers clearly indicate sustained demand expansion, the official added. 



Source link

Continue Reading

Trending